title: Induction therapy for adult small bowel transplant with Campath-1H.
authors.affiliation: Division of Transplantation, Department of Surgery, University of Miami/Jackson Memorial Medical Center, 1801 NW 9th Avenue, Miami, FL 33136, USA.
authors.forename: S
authors.initials: S
authors.lastname: Nishida
authors.forename: D
authors.initials: D
authors.lastname: Levi
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: J
authors.initials: J
authors.lastname: Madariaga
authors.forename: J
authors.initials: J
authors.lastname: Nery
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
mesh_terms: D000328:Adult; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007422:Intestines / Q000637:transplantation*; D007958:Leukocyte Count; D008297:Male; D012778:Short Bowel Syndrome / Q000601:surgery*; D014184:Transplantation, Homologous / Q000276:immunology / Q000502:physiology*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab